A Study of T3011 in Patients With BCG-Unresponsive NMIBC or BCG-Exposed, Chemotherapy-Unresponsive NMIBC

Clinical trial NCT06971614 · RECRUITING

Trial details

NCT number: NCT06971614
Sponsor: ImmVira Pharma Co. Ltd
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Nonmuscle-invasive Bladder Cancer

Start date: 2025-06-09
Primary completion: 2028-12-31
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.